Joris Winderickx

Corporate Officer/Principal presso reMYND NV

Commercial Services

Consumer Services

Health Technology

Posizioni attive di Joris Winderickx

Società	Posizione	Inizio	Fine
reMYND NV reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium.	Corporate Officer/Principal	30/05/2012	-
	Direttore/Membro del Consiglio	01/01/2002	30/05/2012
	Fondatore	09/11/2009	-

Società	Posizione	Inizio	Fine
Royal Flemish Chemical Society	Fondatore	-	-
ADx NeuroSciences NV ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium.	Direttore/Membro del Consiglio	-	-
Katholieke Universiteit Leuven	Corporate Officer/Principal	-	-

Katholieke Universiteit Leuven

Doctorate Degree

Distribuzione geografica

Belgio

Posizioni

Director/Board Member	2
Founder	2
Corporate Officer/Principal	2

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	3
reMYND NV reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium.	Commercial Services
Royal Flemish Chemical Society
ADx NeuroSciences NV ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium.	Health Technology